https://www.selleckchem.com/products/MDV3100.html
An important clindamycin-rifampicin pharmacokinetic (PK) interaction has been reported, but the potential influence of the clindamycin administration route on that interaction is unknown. This prospective, observational, comparative PK study was undertaken to characterize and analyse the impact of the route, comparing the rifampicin enzyme-inductor effects on clindamycin clearance (CLclin) for oral versus intravenous (IV) administration. Patients with bone-and-joint infections (BJIs) were treated with clindamycin monotherapy (n=2 or c
Like
Comment
Share
